The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes
Open accessAbstract
The BRCA1 gene product and its stoichiometric binding partner, BARD1, play a vital role in the cellular response to DNA damage. However, how they acquire specific biochemical functions after DNA damage is poorly understood. Following exposure to genotoxic stress, DNA damage-specific interactions were observed between BRCA1/BARD1 and the DNA damage-response proteins, TopBP1 and Mre11/Rad50/NBS1. Two distinct DNA damage-dependent super complexes emerged; their activation was dependent, in part, on the actions of specific checkpoint kinases, and each super complex contributed to a distinctive aspect of the DNA damage response. The results support a new, multifactorial model that describes how genotoxic stress enables BRCA1 to execute a diverse set of DNA damage-response functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Three proteins, Abraxas (also known as Abra1, FAM175A, CCDC98), Bach1 (also known as Brip1, FancJ) and CtIP (also known as RBBP8), directly interact with the BRCA1 BRCT domains through the pSPxF motif in a phosphorylation-dependent manner forming mutually exclusive complexes, which were thus named as the A, B and C complexes of BRCA1 (Greenberg et al., 2006; Kim et al., 2007; Liu et al., 2007;”
From The BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression (2014) · cites this paper as Greenberg et al., 2006
In the citing paper
“FANCJ helicase activity induced in S phase is also required for FANCJ to promote S phase progression and possibly intra-S phase checkpoints [71,72].”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168 · cited 1×
“Testament to this relationship is the observation that a significant fraction of inherited cancer syndromes stem from germline mutations in DNA repair and checkpoint control genes (Lengauer et al. 1998; Vessey et al. 1999).”
BackgroundThe DNA damage response: putting checkpoints in perspective
Zhou, B.-B. S., & Elledge, S. J. (2000) · Nature · doi:10.1038/35044005 · Cited by 3,213
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Megabase Chromatin Domains Involved in DNA Double-Strand Breaks in Vivo
Rogakou, E. P., Boon, C., Redon, C., & Bonner, W. M. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.905 · Cited by 2,422
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Cancer Susceptibility and the Functions of BRCA1 and BRCA2
Venkitaraman, A. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00615-3 · Cited by 1,713
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Self-citationBrca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Flagged first, then by citations
Research works printed but not linked: 5
- 1998, Cancer Res., 58, 4375
- 1999, Cancer Res., 59, 4375
- 2002, Cancer Res., 62, 4588
- 2003, Cancer Res., 63, 3049
- 2002, Nat. Genet., 11, 11
Cited by
Sorted by citations
Items 101–200 of 307
LncRNAs in DNA damage response and repair in cancer cells
Su, M., Wang, H., Wang, W., Wang, Y., Ouyang, L., Chen, P., Xia, L., Cao, D., & Liao, Q. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy022 · Cited by 72
CtIP-dependent DNA resection is required for DNA damage checkpoint maintenance but not initiation
Kousholt, A. N., Fugger, K., Hoffmann, S., Larsen, B. D., Menzel, T., Sartori, A. A., & Sørensen, C. S. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201111065 · Cited by 77
BRCAness: a deeper insight into basal-like breast tumors
Summa, S. D., Pinto, R., Sambiasi, D., Petriella, D., Paradiso, V., Paradiso, A., & Tommasi, S. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt306 · Cited by 73
AGO2 and its partners: a silencing complex, a chromatin modulator, and new features
Li, X., Wang, X., Cheng, Z., & Zhu, Q. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1738331 · Cited by 71
Rapid Recruitment of BRCA1 to DNA Double-Strand Breaks Is Dependent on Its Association with Ku80
Wei, L., Lan, L., Hong, Z., Yasui, A., Ishioka, C., & Chiba, N. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01075-08 · Cited by 78
Raghunandan, M., Chaudhury, I., Kelich, S. L., Hanenberg, H., & Sobeck, A. (2015) · Cell Cycle · doi:10.4161/15384101.2014.987614 · Cited by 74
Weberpals, J. I., Clark-Knowles, K. V., & Vanderhyden, B. C. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.3902 · Cited by 71
Recognition of DNA double strand breaks by the BRCA1 tumor suppressor network
Greenberg, R. A. (2008) · Chromosoma · doi:10.1007/s00412-008-0154-8 · Cited by 69
Self-citationN Terminus of CtIP Is Critical for Homologous Recombination-mediated Double-strand Break Repair
Yuan, J., & Chen, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.023424 · Cited by 69
Fang, Y., Zhang, Q., Wang, X., YANG, X., Wang, X., Huang, Z., Jiao, Y., & Wang, J. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3327 · Cited by 65
BRCA1 Mutations in Cancer: Coordinating Deficiencies in Homologous Recombination with Tumorigenesis
Krais, J. J., & Johnson, N. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1830 · Cited by 66
Stok, C., Kok, Y. P., van den Tempel, N., & van Vugt, M. A. T. M. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab151 · Cited by 67
Nikkilä, J., Coleman, K. A., Morrissey, D., Pylkäs, K., Erkko, H., Messick, T. E., Karppinen, S.-M., Amelina, A., Winqvist, R., & Greenberg, R. A. (2009) · Oncogene · doi:10.1038/onc.2009.33 · Cited by 63
Self-citationBharti, S. K., Khan, I., Banerjee, T., Sommers, J. A., Wu, Y., & Brosh, R. M. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1569-4 · Cited by 61
The Deubiquitylating Enzyme USP4 Cooperates with CtIP in DNA Double-Strand Break End Resection
Liu, H., Zhang, H., Wang, X., Tian, Q., Hu, Z., Peng, C., Jiang, P., Wang, T., Guo, W., Chen, Y., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.056 · Cited by 62
Sakamoto, S., Iijima, K., Mochizuki, D., Nakamura, K., Teshigawara, K., Kobayashi, J., Matsuura, S., Tauchi, H., & Komatsu, K. (2007) · Oncogene · doi:10.1038/sj.onc.1210428 · Cited by 58
Dual role of CDKs in DNA repair: To be, or not to be
Yata, K., & Esashi, F. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.09.002 · Cited by 62
BRCA1 Mutational Complementation Induces Synthetic Viability
Nacson, J., Marcantonio, D. D., Wang, Y., Bernhardy, A. J., Clausen, E., Hua, X., Cai, K. Q., Martı́nez, E., Feng, W., Callén, E., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.006 · Cited by 53
BRCA1 and Its Network of Interacting Partners
Christou, C. M., & Kyriacou, K. C. (2013) · Biology · doi:10.3390/biology2010040 · Cited by 58
Fanconi Anemia Group J Helicase and MRE11 Nuclease Interact To Facilitate the DNA Damage Response
Suhasini, A. N., Sommers, J. A., Muniandy, P. A., Coulombe, Y., Cantor, S. B., Masson, J., Seidman, M. M., & Brosh, R. M. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01256-12 · Cited by 57
Self-citationLiu, Y., Cussiol, J. R. R., Dibitetto, D., Sims, J. R., Twayana, S., Weiss, R. S., Freire, R., Marini, F., Pellicioli, A., & Smolka, M. B. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201607031 · Cited by 55
Reyngold, M., Nandula, S. V., Modi, A. P., Wang, S., Jasin, M., Murty, V. V. V. S., Ludwig, T., & Baer, R. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705198200 · Cited by 56
BRCA1 Ubiquitinates RPB8 in Response to DNA Damage
Wu, W., Nishikawa, H., Hayami, R., Sato, K., Honda, A., Aratani, S., Nakajima, T., Fukuda, M., & Ohta, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3187 · Cited by 57
Suhasini, A. N., Sommers, J. A., Mason, A. C., Voloshin, O. N., Camerini‐Otero, R. D., Wold, M. S., & Brosh, R. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.012229 · Cited by 53
Peng, M., Xie, J., Ucher, A. J., Stavnezer, J., & Cantor, S. B. (2014) · The EMBO Journal · doi:10.15252/embj.201387530 · Cited by 54
Self-citationUveal melanoma: progress in molecular biology and therapeutics
Li, Y., Shi, J., Yang, J., Ge, S., Zhang, J., Jia, R., & Fan, X. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920965852 · Cited by 55
Identification of Filamin A as a BRCA1-interacting protein required for efficient DNA repair
Velkova, A., Carvalho, M. A., Johnson, J., Tavtigian, S. V., & Monteiro, Á. N. A. (2010) · Cell Cycle · doi:10.4161/cc.9.7.11256 · Cited by 55
Homologs of Breast Cancer Genes in Plants
Trapp, O., Seeliger, K., & Puchta, H. (2011) · Frontiers in Plant Science · doi:10.3389/fpls.2011.00019 · Cited by 56
Zhang, J. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-11 · Cited by 58
Targeting DNA repair in breast cancer: A clinical and translational update
Amir, E., Šeruga, B., Serrano, R., & Ocaña, A. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.03.006 · Cited by 52
Nittis, T., Guittat, L., LeDuc, R. D., Dao, B., Duxin, J. P., Rohrs, H. W., Townsend, R. R., & Stewart, S. A. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900490-mcp200 · Cited by 52
The BRCA1 ubiquitin ligase and homologous recombination repair
Ohta, T., Sato, K., & Wu, W. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.005 · Cited by 53
Cousineau, I., & Belmaaza, A. (2011) · Molecular Genetics and Genomics · doi:10.1007/s00438-011-0612-5 · Cited by 57
BARD1 Gene Polymorphisms Confer Nephroblastoma Susceptibility
Fu, W., Zhu, J., Xiong, S.-W., Jia, W., Zhang, Z., Zhu, S.-B., Hu, J.-H., Wang, F.-H., Xia, H., He, J., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.01.038 · Cited by 53
BGL3 lncRNA mediates retention of the BRCA1/BARD1 complex at DNA damage sites
Hu, Z., Mi, S., Zhao, T. S., Peng, C., Peng, Y., Chen, L., Zhu, W., Yao, Y., Song, Q., Li, X., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019104133 · Cited by 49
Battaglia, A. (2014) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s15239 · Cited by 47
Akamatsu, Y., Murayama, Y., Yamada, T., Nakazaki, T., Tsutsui, Y., Ohta, K., & Iwasaki, H. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01828-07 · Cited by 48
Zhang, F., Wu, J., & Yu, X. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.039404 · Cited by 51
Tian, F., Sharma, S., Zou, J., Lin, S., Wang, B., Rezvani, K. S., Wang, H., Parvin, J. D., Ludwig, T., Canman, C. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306534110 · Cited by 48
Decapping protein EDC4 regulates DNA repair and phenocopies BRCA1
Hernández, G., Ramı́rez, M. J., Minguillón, J., Quiles, P., Ponce, G. R. D. G., Aza‐Carmona, M., Bogliolo, M., Pujol, R. M., Prados‐Carvajal, R., Fernández‐Rodríguez, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03433-3 · Cited by 49
Functions of TopBP1 in preserving genome integrity during mitosis
Bagge, J., Oestergaard, V. H., & Lisby, M. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.08.009 · Cited by 39
Understanding the functions of BRCA1 in the DNA-damage response
Yun, M. H., & Hiom, K. J. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370597 · Cited by 49
Classification of Non-Small Cell Lung Cancer Based on Copy Number Alterations
Li, B., You, J., Huang, T., & Cai, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088300 · Cited by 44
Wu, J., Liu, C., Chen, J., & Yu, X. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.351007 · Cited by 48
Targeting DNA repair: the genome as a potential biomarker
Nesic, K., Wakefield, M. J., Kondrashova, O., Scott, C. L., & McNeish, I. A. (2017) · The Journal of Pathology · doi:10.1002/path.5025 · Cited by 47
DNA damage repair and cardiovascular diseases
Shukla, P. C., Singh, K. K., Yanagawa, B., Teoh, H., & Verma, S. (2010) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(10)71055-2 · Cited by 46
The BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression
Castillo, A., Paul, A., Sun, B., Huang, T. H., Wang, Y., Yazinski, S. A., Tyler, J., Li, L., You, M. J., Zou, L., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.050 · Cited by 39
Molecular markers of paragangliomas/pheochromocytomas
Zhikrivetskaya, S. O., Snezhkina, A. V., Zaretsky, A. R., Alekseev, B. Y., Pokrovsky, A. V., Golovyuk, A. L., Melnikova, N. V., Stepanov, O. A., Kalinin, D. V., Moskalev, A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15201 · Cited by 45
Gupta, R., Sharma, S., Doherty, K. M., Sommers, J. A., Cantor, S. B., & Brosh, R. M. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl964 · Cited by 41
Self-citationPolo-like kinase 1 mediates BRCA1 phosphorylation and recruitment at DNA double-strand breaks
Chabalier-Taste, C., Brichese, L., Racca, C., Canitrot, Y., Calsou, P., & Larminat, F. (2016) · Oncotarget · doi:10.18632/oncotarget.6825 · Cited by 42
Lung, M. L., Dai, W., & Ko, J. M. Y. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814936-2.00002-x · Cited by 46
Loizidou, M. A., Cariolou, M. A., Neuhausen, S. L., Newbold, R. F., Bashiardes, E., Marcou, Y., Michael, T., Daniel, M., Kakouri, E., Papadopoulos, P., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0518-7 · Cited by 39
Structural and Functional Basis of JAMM Deubiquitinating Enzymes in Disease
Pan, X., Wu, S., Wei, W., Chen, Z., Wu, Y., & Gong, K. (2022) · Biomolecules · doi:10.3390/biom12070910 · Cited by 41
Wu, Y., Sommers, J. A., Loiland, J., Kitao, H., Kuper, J., Kisker, C., & Brosh, R. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.351338 · Cited by 39
Lee, D., Apelt, K., Lee, S.-O., Chan, H., Luijsterburg, M. S., Leung, J. W. C., & Miller, K. M. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac160 · Cited by 35
Wu, Y., & Brosh, R. M. (2009) · Current Molecular Medicine · doi:10.2174/156652409788167159 · Cited by 37
Hüper, G., & Marks, J. R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4065 · Cited by 36
Sharma, A., Biswas, A., Liu, H., Sen, S., Paruchuri, A., Katsonis, P., Lichtarge, O., Dakal, T. C., Maulik, U., Gromiha, M. M., et al. (2019) · Cancers · doi:10.3390/cancers11101600 · Cited by 35
Rebbeck, T. R., Mitra, N., Domchek, S. M., Wan, F., Chuai, S., Friebel, T. M., Panossian, S., Spurdle, A. B., Chenevix‐Trench, G., kConFab, et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0625 · Cited by 36
Self-citationArenzana, T. L., Lianoglou, S., Seki, A., Eidenschenk, C., Cheung, T. K., Seshasayee, D., Hagenbeek, T. J., Sambandam, A., Noubade, R., Peng, I., et al. (2018) · Science Immunology · doi:10.1126/sciimmunol.aal1953 · Cited by 37
Wiltshire, T. D., Senft, J., Wang, Y., Konat, G. W., Wenger, S. L., Reed, E., & Wang, W. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.029504 · Cited by 34
Nath, S., & Nagaraju, G. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008701 · Cited by 34
Phosphorylation-dependent assembly of DNA damage response systems and the central roles of TOPBP1
Day, M., Oliver, A. W., & Pearl, L. H. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103232 · Cited by 34
Yeast Screens Identify the RNA Polymerase II CTD and SPT5 as Relevant Targets of BRCA1 Interaction
Bennett, C. B., Westmoreland, T. J., Verrier, C. S., Blanchette, C., Winsor, T. S., Phatnani, H. P., Mishina, Y. V., Hüper, G., Selim, A. L., Madison, E. R., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001448 · Cited by 33
Fine-tuning the ubiquitin code at DNA double-strand breaks: deubiquitinating enzymes at work
Citterio, E. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00282 · Cited by 30
POGZ promotes homology‐directed DNA repair in an HP1‐dependent manner
Heath, J., Simo‐Cheyou, E. R., Findlay, S., Luo, V. M., Carpio, E. P., Lee, J., Djerir, B., Chen, X., Morin, T., Lebeau, B., et al. (2021) · EMBO Reports · doi:10.15252/embr.202051041 · Cited by 33
Domagała, P., Jakubowska, A., Jaworska–Bieniek, K., Białkowska, K., Durda, K., Kurlapska, A., Cybulski, C., & Lubiński, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130393 · Cited by 31
Assessing the link between BACH1/FANCJ and MLH1 in DNA crosslink repair
Cantor, S. B., & Xie, J. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20568 · Cited by 29
Self-citationRAP80 phase separation at DNA double-strand break promotes BRCA1 recruitment
Qin, C., Wang, Y., Zhou, J., Shi, J., Zhao, W.-W., Zhu, Y., Bai, S.-M., Feng, L., Bie, S.-Y., Zeng, B., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad686 · Cited by 29
BAP1 Is a Novel Target in HPV-Negative Head and Neck Cancer
Liu, X., Kumar, M., Yang, L., Molkentine, D. P., Valdecanas, D. R., Yu, S., Meyn, R. E., Heymach, J. V., & Skinner, H. D. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1573 · Cited by 28
Bharti, S. K., Sommers, J. A., Awate, S., Bellani, M. A., Khan, I., Bradley, L. M., King, G. A., Seol, Y., Vidhyasagar, V., Wu, Y., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky403 · Cited by 27
Sevcik, J., Falk, M., Macůrek, L., Kleiblová, P., Lhota, F., Hojny, J., Štefančíková, L., Janatová, M., Bártek, J., Stribrna, J., et al. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.02.008 · Cited by 28
FANCJ Localization by Mismatch Repair Is Vital to Maintain Genomic Integrity after UV Irradiation
Guillemette, S., Branagan, A. M., Peng, M., Dhruva, A., Schärer, O. D., & Cantor, S. B. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2474 · Cited by 28
Self-citationMaqbool, I., Sudharsan, M., Kanimozhi, G., Al‐Rashood, S. T., Khan, H. A., & Prasad, N. R. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00707 · Cited by 28
BRCA1 downregulates the kinase activity of Polo-like kinase 1 in response to replication stress
Zou, J., Rezvani, K. S., Wang, H., Lee, K. S., & Zhang, D. (2013) · Cell Cycle · doi:10.4161/cc.25349 · Cited by 28
Mok, M. T. S., & Henderson, B. R. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.09.007 · Cited by 26
The Role of BRCA1/2-Mutated Tumor Microenvironment in Breast Cancer
Miklikova, S., Trnkova, L., Plavá, J., Boháč, M., Kuniaková, M., & Cihova, M. (2021) · Cancers · doi:10.3390/cancers13030575 · Cited by 27
A synergetic effect of BARD1 mutations on tumorigenesis
Li, W., Gu, X., Liu, C., Shi, Y., Wang, P., Zhang, N., Wu, R., Leng, L., Xie, B., Song, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21519-3 · Cited by 28
BARD1germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma
Randall, M. P., Egolf, L. E., Vaksman, Z., Samanta, M., Tsang, M., Groff, D., Evans, P., Rokita, J. L., Layeghifard, M., Shlien, A., et al. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad182 · Cited by 25
Takeshita, T., Wu, W., Koike, A., Fukuda, M., & Ohta, T. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-0961-5 · Cited by 26
The UPS: a promising target for breast cancer treatment
Sato, K., Rajendra, E., & Ohta, T. (2008) · BMC Biochemistry · doi:10.1186/1471-2091-9-s1-s2 · Cited by 26
Zhu, B., Yan, K., Li, L., Lin, M., Zhang, S., He, Q., Zheng, D., Yang, H., & Shao, G. (2014) · Oncogene · doi:10.1038/onc.2014.229 · Cited by 25
Goldstein, M., & Kastan, M. B. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0400 · Cited by 26
Gu, B., & Chen, P. (2009) · Cell Cycle · doi:10.4161/cc.8.9.8322 · Cited by 26
BRCA1–BARD1 combines multiple chromatin recognition modules to bridge nascent nucleosomes
Burdett, H., Foglizzo, M., Musgrove, L. J., Kumar, D., Clifford, G., Campbell, L. J., Heath, G. R., Zeqiraj, E., & Wilson, M. D. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad793 · Cited by 26
RNF19A-mediated ubiquitination of BARD1 prevents BRCA1/BARD1-dependent homologous recombination
Zhu, Q., Huang, J., Huang, H., Li, H., Yi, P., Kloeber, J. A., Yuan, J., Chen, Y., Deng, M., Luo, K., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27048-3 · Cited by 24
Sevcik, J., Falk, M., Kleiblová, P., Lhota, F., Štefančíková, L., Janatová, M., Weiterová, L., Lukášová, E., Kozubek, S., Pohlreich, P., et al. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2011.12.023 · Cited by 24
Brca1 in immunoglobulin gene conversion and somatic hypermutation
Longerich, S., Orelli, B. J., Martin, R. W., Bishop, D. K., & Storb, U. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.10.002 · Cited by 24
Therapeutic potential of PARP inhibitors for metastatic breast cancer
Irshad, S., Ashworth, A., & Tutt, A. N. J. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.11.52 · Cited by 23
Maresca, L., Lodovichi, S., Lorenzoni, A., Cervelli, T., Monaco, R., Spugnesi, L., Tancredi, M., Falaschi, E., Zavaglia, K. M., Landucci, E., et al. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00397 · Cited by 25
Akagawa, R., Trinh, H. T., Saha, L. K., Tsuda, M., Hirota, K., Yamada, S., Shibata, A., Kanemaki, M. T., Nakada, S., Takeda, S., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101027 · Cited by 24
A DNA Repair BRCA1 Estrogen Receptor and Targeted Therapy in Breast Cancer
Ratanaphan, A. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131114898 · Cited by 25
FOXP3 Regulates Sensitivity of Cancer Cells to Irradiation by Transcriptional Repression of BRCA1
Li, W., Katoh, H., Wang, L., Yu, X., Du, Z., Yan, X., Zheng, P., & Liu, Y. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2481 · Cited by 22
Yan, J., Yang, X.-P., Kim, Y. S., & Jetten, A. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5950 · Cited by 22
Dimitrov, S. D., Lu, D., Naetar, N., Hu, Y., Pathania, S., Kanellopoulou, C., & Livingston, D. M. (2013) · Genes & Development · doi:10.1101/gad.225045.113 · Cited by 22
Self-citationDkhissi, F., Aggoune, D., Pontis, J., Sorel, N., Piccirilli, N., Corf, A. L., Guilhot, F., Chomel, J., Ait‐Si‐Ali, S., & Turhan, A. G. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.04.013 · Cited by 21
Hirosawa, T., Ishida, M., Ishii, K., Kanehara, K., Kudo, K., Ohnuma, S., Kamei, T., Motoi, F., Naitoh, T., Selaru, F. M., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206643 · Cited by 21
Li, S., Yoshida, Y., Kobayashi, E., Adachi, A., Hirono, S., Matsutani, T., Mine, S., Machida, T., Ohno, M., Nishi, E., et al. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4690 · Cited by 21
Vohhodina, J., Toomire, K. J., Petit, S. A., Micevic, G., Kumari, G., Botchkarev, V. V., Li, Z., Livingston, D. M., & Hu, Y. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908003117 · Cited by 22
Self-citationDeletion of Chromosomes 13q and 14q Is a Common Feature of Tumors with BRCA2 Mutations
Rouault, A., Banneau, G., MacGrogan, G. M., Jones, N. B., Elarouci, N., Barouk-Simonet, E., Venat, L., Coupier, I., Letouzé, É., de Reyniès, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052079 · Cited by 20
Metadata
- Authors
- Greenberg, R. A., Sobhian, B., Pathania, S., Cantor, S. B., Nakatani, Y., & Livingston, D. M.
- Affiliations
- Harvard University (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2006-01-01
- Volume
- 20
- Issue
- 1
- Pages
- 34-46
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC1356099
- OpenAlex
- W2164458581
- Cited by
- 308
- References
- 61
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 4 · 2023: 9 · 2022: 12 · 2021: 17 · 2020: 13 · 2019: 4 · 2018: 14 · 2017: 12 · 2016: 10 · 2015: 19 · 2014: 21 · 2013: 19 · 2012: 22
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Funders
- Leukemia Research Foundation
- Broad Institute
- Österreichischen Akademie der Wissenschaften
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- BRCA1, BARD1, DNA damage response, TopBP1, Mre11-Rad50-Nbs1, checkpoint kinase, genotoxic stress
- MeSH terms
- MRE11 Homologue Protein, Carrier Proteins, Cell Cycle, DNA Damage, DNA Repair, DNA-Binding Proteins, Humans, Nuclear Proteins, Protein Binding, Acid Anhydride Hydrolases, Cell Cycle Proteins, BRCA1 Protein, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, DNA Repair Enzymes, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review